Cubist Pharma Posts Q4 Loss - Quick Facts

(RTTNews) - Cubist Pharmaceuticals, Inc. (CBST) Thursday reported fourth-quarter loss of $15.5 million or $0.08 per share, compared to a profit of $45.3 million or $0.51 per share in the same period last year.

Adjusted earnings for the quarter was $43.6 million or $0.29 per share. On average, 15 analysts polled by Thomson Reuters expected the company to report a loss of $0.01 per share for the quarter. Analysts' estimates typically exclude special items.

Revenues increased to $299.7 million from $245.9 million last year. Analysts expected revenues of $282.73 million.

Looking ahead, the company now projects full-year revenues in the order of $1.19 billion to $1.275 billion. Analysts currently expect full-year revenues of $1.04 billion.